HIGHLIGHTS
- who: Abir Salek et al. from the University of Montpellier, INSERM, CNRS, Montpellier, France have published the paper: Enhancement of the In Vitro Antitumor Effects of Berberine Chloride When Encapsulated within Small Extracellular Vesicles, in the Journal: Pharmaceutics 2022, 14, 1913. of /2022/
- what: In the present study, Berberine hydrochloride (BRB) therapeutic properties have been evaluated. The authors propose sEVs as biological carriers to enhance both stability and efficacy of BRB, and therefore its anti-tumoral and anti-angiogenic pharmacological properties. This study shows that sEVs are potential stable BRB carriers with homogeneous particle size . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.